Dr. Wendy Post is professor of medicine at the Johns Hopkins University School of Medicine and holds a joint appointment as professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Lou and Nancy Grasmick Professor of Cardiology. Dr. Post is a cardiologist at the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease and the Echocardiography Laboratory and is associate faculty at the Welch Center for Prevention, Epidemiology, and Clinical Research at Johns Hopkins University. She is Director of Cardiovascular Research for the Division of Cardiology and Director of Research for the Hopkins Cardiovascular Fellowship Training Program. Dr. Post received her undergraduate degree in biology from Harvard University. She earned her medical degree from Columbia College of Surgeons and Physicians, Columbia University. After completing her internship and residency at Harvard Medical School’s Beth Israel Hospital, Dr. Post received her master’s degree in epidemiology from the Harvard School of Public Health. She was a research fellow at the Framingham Heart Study, in Framingham, Mass., and completed a fellowship in cardiology at The Johns Hopkins Hospital. Dr. Post joined the Johns Hopkins faculty in 1997. Dr. Post’s research interests include prediction and prevention of coronary heart disease and sudden cardiac death, noninvasive imaging of subclinical atherosclerosis, genetics of cardiovascular disease, sex and racial/ethnic differences in cardiovascular disease, and cardiovascular disease in HIV/AIDS and COVID-19. She is the chair of the steering committee, and the principal investigator for the Hopkins field center for the NIH-funded Multi-Ethnic Study of Atherosclerosis (MESA). Dr. Post also leads Multicenter AIDS Cohort Study (MACS) Cardiovascular Disease sub-studies. She has been the PI for three R01 grants from NHLBI investigating cardiovascular disease in HIV, and is dual PI on the cardiology NHLBI training grant, which has been continuously funded for over 45 years. Dr. Post is a manuscript reviewer for multiple publications and is currently associate editor of Circulation. She has over 350 peer-reviewed research publications. Dr. Post was elected as a member of the American Society for Clinical Investigation (ASCI) in 2015. She mentors multiple medical students, medical house staff, fellows and junior faculty. She was a member of the Hopkins Professorial Promotions Committee and a former Johns Hopkins University Provost Fellow. She was co-chair of the Johns Hopkins University Committee on the Biomedical Scientific Workforce. Dr. Post is rated as a Distinguished provider by MediFind in the treatment of Cardiac Arrest. Her top areas of expertise are Atherosclerosis, Coronary Heart Disease, Carotid Artery Disease, Hormone Replacement Therapy (HRT), and Aortic Valve Replacement.

Jonathan Chrispin, M.D., is an Associate Professor of Medicine in the Johns Hopkins Medicine Division of Cardiology, Electrophysiology and Arrhythmia, as well as an Associate Professor of Biomedical Engineering at Johns Hopkins University. Dr. Chrispin focuses on all aspects of clinical electrophysiology, including pacemaker/defibrillator implantation and complex catheter ablation for atrial and ventricular arrhythmias. Dr. Chrispin received his Bachelor of Arts degree from Harvard University. He received his Doctor of Medicine degree from Vanderbilt University. He completed intern and residency training in internal medicine at The Johns Hopkins Hospital, where he also completed a fellowship in cardiovascular disease and served as chief clinical cardiac electrophysiology fellow. He is a member of the American College of Cardiology, the American Heart Association, and the Heart Rhythm Society. Dr. Chrispin directs the Ventricular Arrhythmia Ablation and Research program, focusing on using advanced cardiac imaging to better understand the structural substrate associated with the development of ventricular arrhythmias and using artificial intelligence to improve the risk stratification of sudden cardiac death. Further, he is involved in developing clinical trials to improve the safety and efficacy of catheter ablation for the treatment of ventricular tachycardia. His work has led to Dr. Chrispin publishing in a number of international journals, including Circulation, the Journal of the American College of Cardiology, Heart Rhythm Journal, Nature Cardiovascular Research, Journal of the American Heart Association, and EP Europace. Dr. Chrispin is rated as a Distinguished provider by MediFind in the treatment of Cardiac Arrest. His top areas of expertise are Ventricular Tachycardia, Arrhythmias, Sarcoidosis, Cardiac Ablation, and Pacemaker Implantation.

Dr. Andreas S. Barth is an Associate Professor in the Division of Cardiology at the Johns Hopkins School of Medicine and Director of the Center for Inherited Heart Diseases. His clinical work focuses on clinical cardiac electrophysiology with a specific focus on inherited arrhythmia syndromes and channelopathies, including long QT syndrome, Brugada syndrome, CPVT and arrhythmogenic cardiomyopathies. Additionally, Dr. Barth participates in a multidisciplinary clinic at Kennedy Krieger Institute providing Cardiology care to patients with muscular dystrophies and mitochondrial disease. Dr. Barth performs pacemaker and defibrillator implantation and complex catheter ablations for atrial and ventricular arrhythmias. His basic research lab explores the relationship between metabolic and arrhythmogenic ion channel remodeling in heart failure and myotonic dystrophy. Dr. Barth earned a combined doctor of medicine and doctor of philosophy from the Ludwig-Maximilians-University in Munich, Germany. He joined the Johns Hopkins faculty in 2016. He has been recognized with the First Prize for the Stanley L. Blumenthal Cardiology Research Award in Clinical Science in the Division of Cardiology at Johns Hopkins Hospital, and as a Young Investigator Award Finalist of the American Heart Association and Heart Rhythm Society. Dr. Barth is rated as an Advanced provider by MediFind in the treatment of Cardiac Arrest. His top areas of expertise are Cardiomyopathy, Arrhythmias, Heart Attack, Cardiac Ablation, and Pacemaker Implantation.

Dr. Myron Weisfeldt is Professor of Medicine and Medical Consultant for Johns Hopkins Technology Ventures. In this position, he provides advice on strategies and evaluation of intellectual property of Johns Hopkins faculty. From 2001 to 2014 Dr. Weisfeldt was the William Osler Professor of Medicine and Chairman of the Department of Medicine at Johns Hopkins School of Medicine. He was also Physician-in-Chief of the Johns Hopkins Hospital. Dr. Weisfeldt received a BA and MD from the Johns Hopkins University. He trained in Cardiology at the Massachusetts General Hospital and the National Institutes of Health and from 1975 to 1991, was Director of the Cardiology Division at the Johns Hopkins. From 1991 to 2001, he was Chairman of the Department of Medicine and Samuel Bard Professor of Medicine at the Columbia University College of Physicians and Surgeons and Director of the Medical Service at the Columbia-Presbyterian Campus of the New York Presbyterian Hospital. Dr. Weisfeldt was Chairman of the Cardiology Advisory Board of the National Heart Lung and Blood Institute from 1987 to 1990 and held the position of President of the American Heart Association in 1990. He is a member of the National Academy of Medicine. His research interests have included heart function, age changes in the heart and circulation, and cardiopulmonary resuscitation. From 2005 to 2018 he was study chair for a large-scale ongoing clinical trials network to conduct randomized definitive trials of devices, drugs and other therapies for out-of-hospital cardiac arrest and severe traumatic injury sponsored by NHLBI and others. The network was called Resuscitation Outcomes Consortium. In November 2022 he will be awarded the Eugene Braunwald Mentoring Award of the American Heart Association. Contact for Research Inquiries1812 Ashland Avenue Suite 110 Baltimore, MD 21205 Email Address: mlw5@jhmi.edu. Dr. Weisfeldt is rated as a Distinguished provider by MediFind in the treatment of Cardiac Arrest. His top areas of expertise are Cardiac Arrest, Ventricular Fibrillation, Paroxysmal Supraventricular Tachycardia (PSVT), and Ventricular Tachycardia.

Dr Halperin received the B.S degree in physics with highest distinction from Purdue University, the M.A. degree in physics from the University of California, Berkeley, and the M.D. degree from Louisiana State University, New Orleans, Louisiana. He is a member of Phi Beta Kappa, an Established Investigator and Fellow of the American Heart Association, and a McClure Fellow of the Johns Hopkins University Applied Physics laboratory. Dr. Halperin is currently a Professor of Medicine, Radiology and Biomedical Engineering at the Johns Hopkins Medical Institutions. He is the co-director of the Cardiovascular Imaging Center of Excellence. He serves on the editorial board of the journal Resuscitation, and is a past chair of the national American Heart Association Advanced Cardiovascular Life Support Subcommittee and a past member of the Emergency Cardiac Care Committee. Ten of his students have received young investigator awards from the American Heart Association and Heart Rhythm Society, and he has ongoing support from the National Institutes of Heath for his research programs. He has over 120 peer-reviewed publications and over 20 patents issued. Dr. Halperin is rated as a Distinguished provider by MediFind in the treatment of Cardiac Arrest. His top areas of expertise are Ventricular Fibrillation, Heart Attack, Ventricular Tachycardia, Cardiac Ablation, and Lithotripsy.

Dr. Hugh Calkins is the Catherine Ellen Poindexter Professor of Cardiology and Director of the Electrophysiology Laboratory and Arrhythmia Service at the Johns Hopkins Hospital. He is an internationally recognized expert on catheter ablation, atrial fibrillation, syncope, arrhythmogenic right ventricular dysplasia (ARVD) and arrhythmia management. Dr. Calkins attended Williams College and Harvard Medical School before training in medicine at Massachusetts General Hospital. He received his cardiology training at Johns Hopkins. His first faculty position was at the University of Michigan, where he directed the Pacemaker Service, and he returned to Johns Hopkins as director of the Arrhythmia Service in 1992. Dr. Calkins is an Associate Editor of the Journal of Cardiovascular Electrophysiology and is on the editorial board of many other cardiology journals. He is a former member of the American Board of Internal Medicine Electrophysiology Boards Test Writing Committee. Dr. Calkins is a fellow of the American College of Cardiology, the American Heart Association and the Heart Rhythm Society. He led a 44-member international task force whose 2012 Expert Consensus Statement gave recommendations for treatment and research of atrial fibrillation. Dr Calkins is a past president of the Heart Rhythm Society and was elected to be a member of the Miler Coulsen Academy of Clinical Excellence in 2014. Dr. Calkins has published more than 500 articles and book chapters on a large variety of cardiac arrhythmias. His research has focused predominantly on catheter ablation, atrial fibrillation, syncope, and arrhythmogenic right ventricular dysplasia. Dr. Calkins has also written extensively on most aspects of heart rhythm disorders and their treatment. Dr. Calkins is rated as a Distinguished provider by MediFind in the treatment of Cardiac Arrest. His top areas of expertise are Atrial Fibrillation, Arrhythmias, Cardiomyopathy, Cardiac Ablation, and Heart Transplant.

Dr. Erin D. Michos is a Professor of Medicine within the Division of Cardiology at Johns Hopkins School of Medicine, with joint appointment in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Director of Women's Cardiovascular Health and the Associate Director of Preventive Cardiology within the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease. Dr. Michos is an internationally known expert in Preventive Cardiology and Women’s Health, having authored >700 publications and 11 book chapters. Her research involves (1) Women’s Cardiovascular Health; (2) Lipids and Lipid management; (3) Cardio-Kidney-Metabolic and Obesity disease management (4) Coronary artery calcium, inflammation and biomarkers of cardiovascular risk. She is the co-Editor-in-Chief for the American Journal of Preventive Cardiology. She is Co-Director of the IMPACT Center (Improving Participation Among Diverse Populations in Cardiovascular Clinical Trials) at Johns Hopkins, funded by the American Heart Association (AHA). She is a co-investigator in several NIH-funded studies including the Multi-Ethnic Study of Atherosclerosis and Atherosclerosis Risk in Communities cohorts. She has served as the Training Director for four AHA Strategic Focused Research Networks. She has mentored over 60 individuals and the recipient of 2 mentoring awards. Additionally, she was the recipient of the Nanette Wegner Award for Women’s Health Medical Leadership by the Women Heart Organization and the Donna Vogel Women’s Health Champion Award by Johns Hopkins University. Dr. Michos completed medical school at Northwestern University, Internal Medicine residency and Cardiology fellowship at the Johns Hopkins Hospital, and a Masters of Health Science degree at the Johns Hopkins Bloomberg School of Public Health. Dr. Michos is rated as an Experienced provider by MediFind in the treatment of Cardiac Arrest. Her top areas of expertise are Atherosclerosis, Vitamin D Deficiency, Peripartum Cardiomyopathy, Percutaneous Coronary Intervention (PCI), and Thrombectomy.

Roger Blumenthal is the Kenneth Jay Pollin Professor of Cardiology, professor of medicine and director of the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease in Baltimore, Maryland. His principal clinical and research interests involve: 1) strategies to improve cardiovascular risk assessment to identify those adults at elevated risk and those at very low risk of cardiovascular disease and 2) the optimal management of atherosclerotic vascular disease. He is an expert in the pathogenesis, treatment and prevention of atherosclerotic vascular disease. Dr. Blumenthal was the principal developer of the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease. He is on the official national spokesperson panel for the American Heart Association and has co-written more than 600 articles dealing with many aspects of coronary heart disease and atherosclerosis management. An experienced writer, Dr. Blumenthal is on the editorial board of Circulation, Cardiology Today, and The American College of Cardiology and Extended Learning Center. He is a fellow of the American College of Cardiology and the American Heart Association’s Epidemiology and Prevention Council. He was co-editor-in-chief of the textbook Preventive Cardiology – A Companion to Braunwald’s Heart Disease. He received his medical degree from Cornell Medical College, where he was awarded the Weiss Prize for Excellence in Clinical Medicine. He did his internal medicine and cardiology fellowship training at The Johns Hopkins Hospital before joining the Johns Hopkins cardiology faculty. Dr. Blumenthal was the 2019 recipient of the Landon School Anthony Kupka Distinguished Alumnus Award. He was co-chairperson of the 2019 American College of Cardiology/American Heart Guideline on prevention of cardiovascular disease. Dr. Blumenthal is rated as an Experienced provider by MediFind in the treatment of Cardiac Arrest. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, Metabolic Syndrome, Percutaneous Coronary Intervention (PCI), and Heart Bypass Surgery.

Dr. Michael J. Blaha MD MPH is Professor of Cardiology and Epidemiology and presently serves as the Director of Clinical Research for the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Director of the Cardiometabolic Clinic, and Program Director for the Preventive Cardiology Fellowship. His clinical interests include primary and secondary prevention of cardiovascular disease, with emphasis on early intervention in patients with advanced subclinical atherosclerosis detected with cardiac computed tomography. Dr. Blaha represents the 4th generation of physicians in his family. After earning a BS in pre-medical studies and classical civilization at the University of Notre Dame in 2001, Dr. Blaha went to Vanderbilt University where in 2006 he received his MD as well as an MPH. in clinical epidemiology and biostatistics. Dr. Blaha then completed his Internal Medicine residency in the Osler Medical Housestaff Training Program at Johns Hopkins in 2009 before completing a fellowship in Cardiology at Johns Hopkins in 2012. In 2018, Dr. Blaha received the Dr. Fred Brancati award at Johns Hopkins for excellence in mentoring. He has mentored over 30 trainees, many of which have gone on to hold prominent academic appointments. In 2021, Dr. Blaha was named to the Clarivate Highly Cited Researcher List, representing the top 1% of world’s researchers, and was first named to the Baltimore Magazine Best Doctors List. In 2022, he received the Arthur S. Agatston Cardiovascular Disease Prevention Award. Clinically, he practices as a preventive cardiologist specializing in cardiometabolic disease and in the interpretation of cardiac CT. His clinic specializes in patients with cardiometabolic disease and advanced subclinical atherosclerosis, and the focused use of an array of lifestyle and pharmacotherapies to mitigate that risk. Dr. Blaha is rated as an Experienced provider by MediFind in the treatment of Cardiac Arrest. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, High Cholesterol, Metabolic Syndrome, and Percutaneous Coronary Intervention (PCI).

Jeremy Pollock is a Cardiologist in Towson, Maryland. Dr. Pollock is rated as an Experienced provider by MediFind in the treatment of Cardiac Arrest. His top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Atrial Fibrillation, Heart Attack, and Apoplexy.

Thomas Guarnieri is a Cardiologist in Towson,, Maryland. Dr. Guarnieri is rated as an Experienced provider by MediFind in the treatment of Cardiac Arrest. His top areas of expertise are Inappropriate Sinus Tachycardia (IST), Familial Ventricular Tachycardia, Atrial Fibrillation, and Arrhythmias.

Stephen Pollock is a Cardiologist in Towson, Maryland. Dr. Pollock is rated as an Experienced provider by MediFind in the treatment of Cardiac Arrest. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, Angina, and Apoplexy.

Matthew Peters is a Cardiologist in Towson,, Maryland. Dr. Peters is rated as an Experienced provider by MediFind in the treatment of Cardiac Arrest. His top areas of expertise are Coronary Heart Disease, Atrial Fibrillation, Paroxysmal Supraventricular Tachycardia (PSVT), and Multifocal Atrial Tachycardia.

Henry Sun is an Interventional Cardiologist in Baltimore,, Maryland. Dr. Sun is rated as an Experienced provider by MediFind in the treatment of Cardiac Arrest. His top areas of expertise are Coronary Heart Disease, Heart Attack, Apoplexy, Heart Bypass Surgery, and Pacemaker Implantation.

Paul Gurbel is a Cardiologist in Baltimore, Maryland. Dr. Gurbel is rated as an Experienced provider by MediFind in the treatment of Cardiac Arrest. His top areas of expertise are Acute Coronary Syndrome, Coronary Heart Disease, Heart Attack, Percutaneous Coronary Intervention (PCI), and Angioplasty.

Brad Pfeffer is a Cardiologist in Baltimore,, Maryland. Dr. Pfeffer is rated as an Experienced provider by MediFind in the treatment of Cardiac Arrest. His top areas of expertise are Heart Attack, Apoplexy, Arterial Embolism, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Hooman Bakhshi is a Cardiologist in Baltimore,, Maryland. Dr. Bakhshi is rated as an Experienced provider by MediFind in the treatment of Cardiac Arrest. His top areas of expertise are Atherosclerosis, Cardiogenic Shock, Coronary Heart Disease, Osteotomy, and Endoscopy.

Sunal Makadia is a Cardiologist in Baltimore,, Maryland. Dr. Makadia is rated as an Experienced provider by MediFind in the treatment of Cardiac Arrest. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, Familial Dilated Cardiomyopathy, and Angina.

Carlos Ince is a Cardiologist in Cockeysville,, Maryland. Dr. Ince is rated as an Experienced provider by MediFind in the treatment of Cardiac Arrest. His top areas of expertise are Arrhythmias, Angina, Atherosclerosis, and Coronary Heart Disease.

Dr. Katherine Wu is a general cardiologist for the Heart and Vascular Institute at Johns Hopkins Medicine with an interest in caring for patients with cardiomyopathies, coronary artery disease, and valvular heart disease as well as those interested in cardiovascular prevention. She has additional expertise in non-invasive cardiology imaging techniques. Dr. Wu received her medical degree from the University of Pennsylvania Health System School of Medicine, and completed her residency and a cardiology fellowship at the Johns Hopkins University School of Medicine. She joined the School of Medicine faculty in 2000. Dr. Wu's research interests include improving individualized risk prediction for sudden cardiac death and heart failure by developing and validating methods that incorporate novel cardiac imaging indices. Her lab is funded by the NIH/NHLBI. Dr. Wu has more than 70 peer-reviewed publications and serves on the editorial board of the Journal of Cardiovascular Magnetic Resonance and Circulation Cardiovascular Imaging and is a standing member of the NIH Clinical and Integrative Cardiovascular Sciences Study Section. Dr. Wu is rated as an Advanced provider by MediFind in the treatment of Cardiac Arrest. Her top areas of expertise are Cardiomyopathy, Atrial Fibrillation, Heart Attack, and Pulmonary Hypertension.